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Abstract

Objective: To assess whether a counselor-initiated adaptation (CI) of the Look AHEAD
Intensive Lifestyle Intervention (ILI) in a military setting was cost-effective relative to a selfpaced adaptation (SP).
Methods: We performed cost-effectiveness analysis from a payer perspective alongside a 20142017 randomized behavioral weight loss trial among 248 active-duty military personnel stationed
at a US Air Force Base in Texas. We calculated incremental cost-effectiveness ratios (ICERs) for
weight loss, reductions in waist circumference, and quality-adjusted life years (QALYs).
Results: After 12 months, the CI adaptation cost more per participant compared to the SP
adaptation ($1,081 vs. $120), but achieved greater weight loss (1.86 vs. 0.06kg), reductions in
waist circumference (1.85 vs. 0.48 cm), and more QALYs (0.871 vs. 0.856). The ICER for CI
relative to the SP adaptation was $61,268 per additional QALY. At willingness-to-pay thresholds
of $50,000 and $100,000 per QALY the CI adaptation was 45 and 49% likely to be costeffective.
Conclusions: The CI delivery of the Look AHEAD ILI may offer a cost-effective approach to
tackle excess weight in the US military.
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Introduction
Evidence of the effectiveness of a health promotion intervention alone is often
insufficient for informed decision making. Public health resources are limited and decision
makers are required to set priorities when allocating scarce resources. Evidence derived from
economic evaluations such as cost-effectiveness analysis of health promotion interventions can
assist decision makers in setting priorities within their monetary budgets. In addition, evidencebased health promotion interventions, including weight loss and weight management
interventions, should be tailored to accommodate the target population’s specific context and
needs.(1, 2) It is valuable to examine the cost-effectiveness of a tailored intervention because
differences in the context and needs from one population to another and unique changes made to
an intervention may affect the costs as well as the effectiveness.(3)
The US military represents one important population that could benefit from tailored
weight loss and weight management interventions. In 2016, the US Department of Defense
(DoD) employed over 3.5 million people, including over 1.2 million active-duty personnel in its
services branches: Army (471,271), Navy (320,101), Air Force (313,723), and Marine Corps
(183,501).(4) The alarming increase in overweight and obesity in the US and around the world
has been the subject of considerable attention.(5) Despite the considerable emphasis on physical
fitness, the US military has not been exempt from these trends.(6) Body mass index (BMI), an
individual’s weight in kilograms divided by the squared height in meters can be used to
categorize individuals into weight categories. Generally, for adults aged 20 years and older, a
BMI between 25.0 and 29.9 kg/m² places an individual in the overweight category and a BMI of
30 kg/m² and greater in the obese category.(7) Based on these categories, approximately 51.0%
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of active-duty service members are overweight and 14.7% are obese compared to 31.6% of the
general US adult population that is estimated to have overweight and 39.6% that is estimated to
be obese.(6, 8) Excess weight and inadequate fitness are associated with higher risk of incident
lower extremity musculoskeletal injury disorders(9) and absenteeism rates among overweight
and obese active-duty personnel and substantial costs for the DoD, including increased medical
care and the cost of recruiting and training replacements for individuals discharged due to fitness
test failure.(10) Dall et al.(10) estimated that 658,000 full time equivalent work days are being
lost each year from absenteeism associated with active-duty personnel who are overweight or
obese at an annual cost of $103 million for the DoD and that the costs for the medical care of
active-duty personnel and their dependents, and military retirees and their dependents associated
with excess weight and obesity exceeds $1 billion annually. The Accession Medical Standards
Analysis and Research Activity estimates that the cost of recruitment, screening, and training is
$75,000 per enlistee, making each fitness-related discharge expensive for the DoD.(11) Members
of the armed forces must meet strict fitness standards (e.g. abdominal circumference). Failure to
meet these standards can result in military discharge which has nontrivial consequences,
including loss of wages, medical benefits and years of service towards pension eligibility.(12)
The Fit Blue study, a randomized, controlled, behavioral, weight loss trial for active-duty
personnel, translated the Look AHEAD Intensive Lifestyle Intervention (ILI)(13) into the
military setting, specifically the Lackland Air Force Base in San Antonio, Texas. The
participants were predominantly (94%) Air Force personnel. Design details for the Fit Blue
intervention have been described previously.(14, 15) In short, the Fit Blue study compared two
adapted versions of the Look AHEAD intervention: a counselor-initiated (CI) and a self-paced
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(SP) condition. The two groups differed in the degree of intervention intensity and the amount of
self-initiation required.
Given the prevalence and adverse consequences of excess weight in the United States
military, examining the potential value (cost versus outcomes) of weight loss and weight
management interventions in this setting is important. The purpose of this study was to assess the
cost-effectiveness of the CI relative to the SP adaptation of the intervention.

Methods
Study Participants and Intervention
The Fit Blue intervention was delivered over the phone and e-mail to make it more
accessible to military personnel who are frequently on brief assignments in different locations,
known as Temporary Duty. Participants in the Fit Blue study were active duty military personnel
stationed at the Lackland Air Force Base. To be eligible for the study, participants had to be over
18 years of age, have a body mass index (BMI) of 25.0 kg/m2 or greater, have computer and
email access, and have at least one year of service left at the Lackland Air Force Base to
minimize the likelihood for loss to follow-up at 12 months. The time-horizon for the intervention
was one year with data collected at baseline, 4 and 12 months. The primary outcome variable
was weight loss at 12 months. Recruitment took place from January 2014 to March 2016, and
data were collected until March 2017. Participants were randomized to CI (n=124) or SP (n=124)
intervention conditions. Trained lay interventionists were either military retirees or staff who had
significant knowledge of military culture. All interventionists had bachelor’s or master’s degrees
in diverse areas of study. During one-on-one phone sessions, interventionists provided strategies
to help participants with weight loss. Self-monitoring sessions consisted of interventionist
6

feedback via email on participants’ food and physical activity using the Lose It!TM Website and
app, and weight uploaded by participants to a secure website through Body TraceTM electronic
scales. Participants in both conditions could receive up to 28 phone sessions and 28 selfmonitoring feedback emails. However, while CI participants received phone calls (phone
sessions) and e-mails (self-monitoring feedback) regularly by interventionists, SP participants
were required to self-initiate requests for those interactions. In addition, only CI participants
were able to receive meal replacements and participate in four four-week-long challenges
designed to increase motivation. Participants who successfully completed a challenge received a
small prize. CI participants also had access to a toolbox which included additional resources such
as exercise videos and cook books. These items could be borrowed but had to be returned prior
to the end of the study.
Model Structure
We developed a decision-tree model using TreeAge Pro 2018 (TreeAge Software Inc,
Williamstown, MA) to estimate the costs and outcomes associated with the Fit Blue intervention
after 12 months. The model included the possible pathways for both intervention conditions and
whether there was a significant weight loss (≥5% of initial body weight lost) or not (<5% of
initial body weight lost). Possible pathways also included whether CI participants had received at
least 75% of possible phone sessions and self-monitoring feedback (28 of each were possible, so
42 out of 56 possible interactions) or not, whether SP participants had any interactions or not,
and whether participants in both conditions returned for the 12-month data collection or not.
Model Input Data
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Model input parameters, including probabilities, were derived from the Fit Blue trial data.
Total costs and per person costs were calculated included the following for both interventions:
intervention materials, shipping costs, telephone and self-monitoring sessions, and incentives for
participation in data collection (Table 1). CI additionally included costs of challenge prizes and
meal replacements. Costs for telephone and self-monitoring sessions were calculated based on
the amount of time that interventionists spent providing telephone sessions and self-monitoring
feedback multiplied by the average hourly rate, including fringe benefits, paid to study
interventionists. Costs for challenge prizes depended on the number of challenges participants
had participated in. The cost of meal replacements was calculated based on the number of meal
replacements consumed multiplied by the average cost per meal replacement. We estimated the
intervention costs in both conditions from a payer perspective. Since all intervention activities
happened outside of participant work time, participant time costs were not considered. Only
costs related to administering the Fit Blue intervention were included. Costs for staff training,
program development, and research costs were excluded. Costs are measured and reported in US
dollars at 2016 price and wage levels.
Our analysis focused on three different outcome measures at 12 months: weight loss (in
kilograms), reduction in waist circumference (in centimeters), and quality-adjusted life years
(QALYs). QALYs were calculated for one year and were estimated based on participant
responses to the Health Utility Index Mark 2 (HUI2®) questionnaire. For missing values at 12
months, we carried forward the baseline observation which is considered a conservative estimate
for completing missing values.(16) We conducted univariate comparisons of mean outcome
measures using Student’s t-tests and chi-square for comparing proportions.
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Cost-Effectiveness Analysis
We calculated three incremental cost-effectiveness ratios (ICERs), corresponding to each
outcome: incremental cost per kilogram of weight loss, incremental cost per centimeter of waist
circumference reduction, and incremental cost per QALY. The ICER is defined as the difference
in costs divided by the difference in the effects of the two intervention adaptations.(17)
To test the sensitivity of our results to model assumptions, we conducted a series of
sensitivity analyses. For the reason that another organization may want to implement the
intervention with existing (more or less expensive) staff which would impact overall intervention
costs, we conducted a one-way sensitivity analysis of hourly wages for intervention staff. Tied to
specific job descriptions (Dietetic Technician vs. Registered Nurse), the low and high entries are
based on national median (2016) hourly wages available from the Bureau of Labor Statistics and
are adjusted for fringe benefits using national 2016 rates (31.5%).(18, 19)
To capture the impact of parameter variability on our study results, we conducted
probabilistic sensitivity analyses. Using a non-parametric bootstrap technique(20), the model
was run 10,000 times, each time resampling the following parameters from the original Fit Blue
trial data with replacement: cost of phone and self-monitoring sessions, cost of meal
replacements, and outcome measures. This non-parametric method allowed us to avoid making
distributional assumptions about the parameter in question.(20) Probabilistic sensitivity analyses
were used to estimate 95% confidence ellipses representing the uncertainty surrounding costs
and effects and to compute cost-effectiveness acceptability curves (CEACs), which plot the
percentage of iterations for which a condition is preferred over its alternative for a range of
willingness-to-pay levels.
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Results
Out of 124 CI participants, 66 (53.2%) attended at least 75% of 56 possible phone
sessions and self-monitoring feedback (at least 42 interactions). Out of 124 SP participants, 8
(6.5%) requested any sessions or feedback. The probability of weight loss ≥5% of initial body
weight was greater in the CI (22.6%) than in the SP condition (9.7%) (p-value = 0.0057). The
probability of lost to follow-up at 12 months was 23.4% in the CI condition, and 37.9% in the SP
condition (p-value = 0.0132). Figure 1 shows the detailed decision-tree including path
probabilities.
Overall intervention costs differed substantially between the two conditions. CI was
estimated to cost overall approximately $133,986 and $1,080.53 per participant, while SP was
estimated to cost overall approximately $14,845 and $119.72 per participant (Table 1). Most of
this difference can be attributed to interventionists’ time costs, because there were a greater
number of phone sessions and self-monitoring emails among CI participants. A portion of the
difference can also be attributed to meal replacements which were not available to SP
participants.
Introductory pay for interventionists was $45,000 per year, or $21.63 per hour. Including
institutional fringe benefits, the total cost of each interventionist was $28.94 per hour. The cost
of meal replacements was calculated based on the number of meal replacements consumed
multiplied by the average cost per meal replacement of $5.08. Participant materials differed
slightly between the two conditions, resulting in slightly higher costs for CI ($129.11) compared
to SP ($104.21; see Table 1).
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CI participants experienced significantly better clinical outcomes compared to SP
participants. Including baseline observations carried forward for missing values, the mean weight
loss was 1.86 kg among CI participants compared to 0.06 kg among SP participants (p-value =
0.0004). CI participants achieved a mean reduction in waist circumference of 1.85 cm compared
to 0.48 cm for those in the SP condition (p-value = 0.0240). CI participants did not achieve
significantly more QALYs at 12 months; 0.87 QALYs compared to 0.85 QALYs for SP
participants (p-value = 0.3879).
Results of the base-case cost-effectiveness analyses are presented in Table 2. While costs
were the same for all outcome measures, ICERs were different due to different denominators:
weight loss in kg, waist circumference reductions in cm, and QALYs. The ICERs for CI relative
to SP were $533.31 per kg lost, $698.77 per cm reduction in waist circumference, and
$61,267.50 per additional QALY.
One-way sensitivity analysis showed that the model was relatively sensitive to
interventionists’ wages. For hourly wages + fringe ranging from $16.66 (Dietetic Technician) to
$43.28 (Registered Nurse)(18, 19) the expected intervention costs ranged from $119.06 to
$120.49 in the SP condition and from $813.90 to $1,392.91 in the CI condition. The ICERs for
CI relative to SP ranged from $385.67 to $706.26 per kg lost, from $505.33 to $925.39 per cm
reduction in waist circumference, and from $44,307.32 to $81,137.53 per additional QALY.
Probabilistic sensitivity analyses conducted with non-parametric bootstrap resampling
revealed uncertainties surrounding the cost-effectiveness results. The incremental costeffectiveness scatterplots depicted in Figures 2-4 show the differences in mean costs and
outcome measures for CI versus SP from 10,000 bootstrap replicates. These scatterplots
highlight the uncertainty in cost and outcome estimates associated with CI relative to SP.(21)
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Each dot in the graphs represents the incremental cost (y-axis) and incremental effectiveness (xaxis) of CI relative to SP for a single iteration of the decision tree. The cost effectiveness
acceptability curves (CEACs) were drawn from these joint distributions of incremental costs and
incremental effects derived from the non-parametric bootstrap resampling. The curves highlight
uncertainty in the ICER estimates by plotting the probabilities that the CI condition is costeffective relative to the SP condition at varying levels of the willingness-to-pay or costeffectiveness threshold.(21) The weight loss CEAC indicates a 49% probability that CI is costeffective when the willingness-to-pay threshold is set at our base case ICER ($533 per additional
kg of weight loss) but approaches 80% for larger willingness-to-pay thresholds (Figure 2). The
CEAC for reduction in waist circumference suggests a 51% probability that CI is cost-effective
when the willingness-to-pay threshold is set at our base case ICER ($699 per additional cm of
reduction in waist circumference) but approaches 70% at higher willingness-to-pay thresholds
(Figure 3). At a willingness-to-pay of $50,000 per additional QALY achieved, the probability CI
is cost-effective is 45%, and at a willingness to pay of $100,000 the probability rises to 49%. The
probability CI is cost-effective in terms of QALYs approaches 52% at higher willingness-to-pay
thresholds (Figure 4).

Discussion
This study assessed the cost-effectiveness of two adaptations of the Look AHEAD ILI in
a US military setting. Several of the findings are notable and worth further discussion. Compared
to SP participants, CI participants accumulated higher average costs but achieved better
outcomes which may help to reduce turnover in the military, saving the cost of recruitment and
training. The observed reduction in waist circumference is particularly notable because waist
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circumference has been described as an important predictor of obesity-related health risks,
including risk for diabetes, coronary heart disease, and stroke.(22) Reduction in waist
circumference is also of particular relevance to the Air Force military branch since abdominal
circumference is currently included in their fitness assessment.(23) Given the estimated
recruitment and training costs of $75,000 per enlistee(11) and the total costs of the CI
intervention of approximately $133,986, the CI intervention would have saved money if
participation in the intervention prevented two CI participants from being discharged due to
fitness test failures.
Although significantly better clinical outcomes among CI participants relative to SP at 12
months did not translate into significantly more QALYs at 12 months, a significant impact on
QALYs was unlikely over such a short time horizon. Ackermann et al.(24) assessed the impact
of weight changes on health-related quality of life in the Diabetes Prevention Program (DPP) and
found that weight-related changes in quality of life scores were very small after one year (0.007
increase for every 5 kg weight loss). We would expect however, that if the improvements made
in the clinical outcomes (weight loss and reduction in waist circumference) are sustained, then in
the future, the difference in QALYs would be greater between the two groups.
Depending on the willingness-to-pay, the CI intervention can be deemed cost-effective.
In our base case cost-effectiveness analysis of the CI relative to the SP condition, ICERs for
clinical outcome measures were $533.31 per kg lost and $698.77 per cm reduction in waist
circumference. Thus, if the decision maker is willing to pay at least $533.31 per additional kg
weight loss or $698.77 per additional cm reduction in waist circumference, CI would be
considered cost-effective relative to SP. In the past, the figure of a lifetime cost of $50,000 per
QALY has been used as society’s threshold to determine the cost-effectiveness of a given
13

healthcare intervention. However, in recent years there has been a call for a much higher
willingness-to-pay threshold and $100,000 and even $150,000 per QALY are being used.(25) In
our base-case analysis, the ICER for CI relative to SP was in below thresholds at $61,267.50 per
additional QALY. Thus, CI would be considered cost-effective at a willingness-to-pay of
$100,000 and $150,000. It is important to note, however, that in our analysis we estimate costs
per QALY over one year for a health system and are unable to provide data from a societal
perspective.
A meta- and cost effectiveness analysis of commercial weight loss interventions reported
an ICER of $155 (2013 US dollars) per kg of weight loss for Weight Watchers relative to a lowcost control intervention.(26) While this suggests that Weight Watchers is more cost-effective
than the CI adaptation,it is unclear how effective a commercial weight loss intervention would be
in a military population. For example, the participants in the Fit Blue trial were considerably
younger (mean 35 years old),face severe occupational consequences related to their physical
fitness and bear significant stress related to potential deployments. Military-specific
characteristics and challenges that may influence the weight loss intervention success in this
setting have been described elsewhere.(14, 15)
We examined two adaptations of the Look AHEAD intervention tailored to a military
setting. The Look AHEAD ILI was modeled after the DPP, but included several modifications,
such as more ambitious nutritional targets, and produced superior weight loss after 1 year.(27)
Despite the differences the two programs also share many features including intervention
sessions focusing on similar topics and the inclusion of toolbox strategies.(27) The DPP has been
reported as cost-effective relative to a placebo intervention among adults with impaired glucose
tolerance.(28, 29) While costs of the more recent Look AHEAD clinical trial have been reported,
14

to date, cost-effectiveness analysis, addressing both costs and outcomes has not yet been
conducted.(30) While several adaptations of the DPP and Look AHEAD interventions have been
successfully translated into different settings(31-35), only a few studies have included economic
evaluations(31-33).
The present study is unique because it presents an economic evaluation of a weight loss
intervention in the US military setting. There have been few randomized controlled trials of
behavioral weight loss or weight management interventions in the US military setting and
economic evaluations have not been conducted alongside these trials.(36-38) To our knowledge,
the present study is the first to conduct a cost-effectiveness analysis of a weight loss intervention
in the US military setting.
Our study results should be interpreted with caution. While the base-case ICERs suggest
that CI could be considered cost-effective, the computed ICERs were sensitive to interventionist
wages. Further, probabilistic sensitivity analysis identified uncertainty around our costeffectiveness estimates. QALYs have become the preferred method to measure effectiveness in
cost-effectiveness analysis. Nevertheless, the use of QALYs has also been criticized because the
thresholds used to infer cost-effectiveness are arbitrary and the methodology used to estimate
QALYs are usually based on subjects’ responses to a questionnaire; therefore representing their
perceived value of their health status.(17, 39) In addition, a one-year time horizon, as was
utilized in our analysis, may not be adequate to detect changes in QALYs because weight loss
may not translate to improvements in quality of life over such a short time-horizon. Over a oneyear time horizon, a clinical measure, such as the reduction in waist circumference, may be more
relevant to the Air Force branch since this measure is part of the fitness assessment. For these
reasons, we conducted analyses with other clinical outcome measures (kg weight loss and cm
15

waist circumference reduction) that may be of interest to a decision maker. However, without
established benchmarks, they do not allow for objective assessments of cost-effectiveness.
Like many behavioral intervention trials, missing follow-up information was a concern.
Best-practices approaches were implemented to minimize impact on our analyses. Our study
time horizon (12 months) was relatively short, limiting our ability to track longer-term health
outcomes. However, 12-month follow-up is common for the weight-loss and weight
management interventions.(40, 41) Since the original Fit Blue trial did not include a nointervention control group, it is unclear how the CI intervention may have performed relative to a
true control population over the 12-month study period. A previous study suggests that Air Force
service members not receiving any intervention gain weight over a one-year period.(37) Finally,
the Fit Blue intervention was implemented in an Air Force setting; our study results may not be
generalizable to other military branches or the general population.

Conclusion
The CI adaptation of the Look AHEAD Intensive Lifestyle Intervention was costeffective relative to the SP adaptation at a willingness-to-pay of $100,000 per QALY. While
ICERs for clinical outcome measures were calculated, established cost-effectiveness thresholds
do not exist for these metrics. Our analyses indicate that they could be deemed cost-effective
across a wide range of willingness-to-pay thresholds. Future studies with a larger sample size, a
longer follow-up period, and non-intervention control group are needed to address limitations of
the current analysis.
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Table 1 - Summary of Costs for participants in the CI and SP condition (in 2016 USD)
Cost Variables
Materials
Scale
Cups and Spoons
Binder
Toolbox
T-Shirt
Total materials costs
Challenge Prizes
T-Shirt
Shoe Laces
Blender Bottle
Reflective Bands
Total Challenge Prizes costs
Meal Replacements
Total Meal Replacements costs
Phone and Self-monitoring Sessions
Total Phone and Self-monitoring Sessions
costs
Data Collection Incentives
4 month incentive: Pedometer
12 month incentive: Water Bottle
Total Data Collection Incentives costs
Total One Year Costs

CI condition (n=124)
Total cost
Per person cost
$ 11,780.00
$ 582.80
$ 2,647.40
$ 1,000.00
$ 16,010.20

SP condition (n=124)
Total cost
Per person cost

$ 95.00 $ 11,780.00
$ 4.70
$ 582.80
$ 21.35
$ 8.06
$ 559.24
$ 129.11 $ 12,922.04

$ 95.00
$ 4.70

$ 4.51
$ 104.21

$ 293.15
$ 144.00
$ 128.00
$ 12.00
$ 577.15

$ 4.51
$ 4.00
$ 8.00
$ 4.00
Mean: $ 4.65
Range: $ 0 – $ 20.51

$ 37,177.98

Mean: $ 299.82
Range: $ 0 - $ 1,600.20

$ 78,118.22

Mean: $ 629.99
Range:$57.84 - $2,158.88

$ 193.28

Mean: $ 1.56
Range: $ 0 - $ 67.48

$ 1,722.20
$ 380.00
$ 2,102.20

$ 15.80
$ 4.00
Mean: $16.95
Range: $ 0 - $ 19.80

$ 1,422.00
$ 308.00
$ 1,730.00

$ 15.80
$ 4.00
Mean: $ 13.95
Range: $ 0 - $ 19.80

$ 133,985.75

Mean: $ 1,080.53 $ 14,845.32
Mean: $ 119.72
Range: $ 186.95 - $ 2,788.74
Range: $ 104.21 - $ 191.49
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Table 2 - Summary of costs, effects, and cost-effectiveness for CI and SP conditions.
Outcome measure at 12 month

CI

SP

condition

condition

Difference

ICER
Point
Estimate

Costs per person, in 2016 USD

1,080.53

119.72

960.81

N.A.

Weight Loss, in kg

1.857

0.056

1.802

533.31

Reduction in Waist Circumference, in cm

1.853

0.478

1.375

698.77

QALY (one-year only)

0.871

0.856

0.016

61,267.50
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Figure 1. – Tree structure used in the decision model with probability paths, costs and outcome measures for each branch. For
participants who did not return for the final 12 month data collection, BOCF indicates baseline observation carried forward.
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Figure 2. - Plot of 10,000 bootstrap replicates of the incremental costs per kilogram of weight
loss and cost-effectiveness acceptability curve representing the proportion of simulations for
which the CI intervention was preferred at a given willingness-to-pay threshold.
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Figure 3. - Plot of 10,000 bootstrap replicates of the incremental costs per centimeter reduction
of waist circumference and cost-effectiveness acceptability curve representing the proportion of
simulations for which the CI intervention was preferred at a given willingness-to-pay threshold.
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Figure 4. - Plot of 10,000 bootstrap replicates of the incremental costs per QALY and costeffectiveness acceptability curve representing the proportion of simulations for which the CI
intervention was preferred at a given willingness-to-pay threshold.
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